World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
22364
World Ranking
2892
National Ranking
1364

Randy A. Albrecht publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Randy A. Albrecht sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 154 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Randy A. Albrecht D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Randy A. Albrecht sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Randy A. Albrecht is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focuses on medicine with substantial engagement in immunology and microbiology. Within these broad fields, their subfields of study include infectious diseases, epidemiology, immunology, molecular biology, and agronomy and crop science.

Their work covers a range of topics related to viral infections and immune responses. Key areas of research include influenza virus studies, investigations on SARS-CoV-2 and COVID-19, clinical research related to COVID-19, respiratory viral infections, interferon and immune responses, animal disease management, epidemiology, and the broader immune response and inflammation.

Randy A. Albrecht has contributed extensively to scientific literature, with frequent publications appearing in several research venues. The most common platforms for their work include bioRxiv (Cold Spring Harbor Laboratory), Nature, Nature Communications, Emerging Microbes & Infections, and the Journal of Virology.

Some of their recent publications include:

  • "Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19" (2020), published in Cell
  • "Animal models for COVID-19" (2020), published in Nature
  • "Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing" (2020), published in Nature
  • "A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics" (2021), published in Nature Biomedical Engineering
  • "Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience" (2021), published in Modern Pathology

Throughout their career, Randy A. Albrecht has frequently collaborated with various researchers. Notable co-authors include Adolfo García-Sastre, Wen-Chun Liu, Michael Schotsaert, Raveen Rathnasinghe, and Florian Krammer.

Best Publications

  • Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.

    Daniel Blanco-Melo;Benjamin E. Nilsson-Payant;Wen Chun Liu;Skyler Uhl

  • Programming the magnitude and persistence of antibody responses with innate immunity.

    Sudhir Pai Kasturi;Ioanna Skountzou;Randy A. Albrecht;Dimitrios Koutsonanos

  • Influenza A Virus NS1 Targets the Ubiquitin Ligase TRIM25 to Evade Recognition by the Host Viral RNA Sensor RIG-I

    Michaela Ulrike Gack;Randy Allen Albrecht;Tomohiko Urano;Tomohiko Urano;Kyung-Soo Inn;Kyung-Soo Inn

  • Meta- and Orthogonal Integration of Influenza “OMICs” Data Defines a Role for UBR4 in Virus Budding

    Shashank Tripathi;Marie O. Pohl;Yingyao Zhou;Ariel Rodriguez-Frandsen

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.

    Laura Riva;Shuofeng Yuan;Xin Yin;Laura Martin-Sancho

  • Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination

    Salah Eddine Bentebibel;Santiago Lopez;Gerlinde Obermoser;Nathalie Schmitt

  • Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with Lysosomes

    Monique Gannagé;Dorothee Dormann;Randy Albrecht;Jörn Dengjel

  • Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency

    Michael J. Ciancanelli;Sarah X.L. Huang;Priya Luthra;Hannah Garner

  • Transcription Elongation Can Affect Genome 3D Structure.

    Sven Heinz;Lorane Texari;Michael G.B. Hayes;Matthew Urbanowski

  • Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus

    Carole R. Baskin;Helle Bielefeldt-Ohmann;Terrence M. Tumpey;Patrick J. Sabourin

  • A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics.

    Longlong Si;Haiqing Bai;Melissa Rodas;Wuji Cao

  • Suppression of the antiviral response by an influenza histone mimic

    Ivan Marazzi;Jessica S. Y. Ho;Jaehoon Kim;Balaji Manicassamy

  • Species-Specific Inhibition of RIG-I Ubiquitination and IFN Induction by the Influenza A Virus NS1 Protein

    Ricardo Rajsbaum;Randy A. Albrecht;May K. Wang;Natalya P. Maharaj

  • Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes

    Rong Hai;Florian Krammer;Gene S. Tan;Natalie Pica

  • Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.

    John Steel;Anice C. Lowen;Lindomar Pena;Matthew Angel

  • Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission

    Unknown

  • Human Responses to Influenza Vaccination Show Seroconversion Signatures and Convergent Antibody Rearrangements

    Katherine J.L. Jackson;Katherine J.L. Jackson;Yi Liu;Krishna M. Roskin;Jacob Glanville

  • A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses

    Shashank Tripathi;Vinod R. M. T. Balasubramaniam;Julia A. Brown;Ignacio Mena

  • Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host

    Andrew Varble;Randy A. Albrecht;Simone Backes;Marshall Crumiller

  • Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.

    Clare Bryce;Zachary Grimes;Elisabet Pujadas;Sadhna Ahuja

  • Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses

    I. Margine;F. Krammer;R. Hai;N. S. Heaton

Frequent Co-Authors

Adolfo García-Sastre
Adolfo García-Sastre Icahn School of Medicine at Mount Sinai
Florian Krammer
Florian Krammer Icahn School of Medicine at Mount Sinai
Peter Palese
Peter Palese Icahn School of Medicine at Mount Sinai
Stuart C. Sealfon
Stuart C. Sealfon Icahn School of Medicine at Mount Sinai
Robert Sebra
Robert Sebra Icahn School of Medicine at Mount Sinai
Benjamin R. tenOever
Benjamin R. tenOever Icahn School of Medicine at Mount Sinai
Donald E. Ingber
Donald E. Ingber Harvard University
Sumit K. Chanda
Sumit K. Chanda Discovery Institute
Virginia Pascual
Virginia Pascual Cornell University
Christopher Benner
Christopher Benner University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career opportunities. Many students begin with foundational programs such as an easiest absn to get into, which offers a fast track to becoming a Registered Nurse (RN). This path provides a strong clinical background valuable in immunology research and patient care.

Another accessible option includes the easiest lpn programs to get into, allowing entry into nursing with less time and a more flexible schedule. Licensed Practical Nurses play critical roles in supporting immunological health environments, especially in community and long-term care settings.

For advanced practice, pursuing the easiest np program can lead to becoming a Nurse Practitioner. This role often involves patient education and managing care plans related to immunology conditions, making it a vital link between research and clinical application.

Specializing further, mental health nursing ties closely with immunological health. Programs recognized among the best pmhnp programs provide strong clinical placements for Psychiatric Mental Health Nurse Practitioners, who address the psychological impacts connected with immune system disorders.

Best Scientists Citing Randy A. Albrecht

Trending Scientists

Recently Published Articles